[1]
2025. CRISPR/Cas9 mediated next generation gene therapy in chronic myeloid leukemia: CRISPR/Cas9 and CML. Indian Journal of Experimental Biology (IJEB). 63, 01 (Jan. 2025), 52–65. DOI:https://doi.org/10.56042/ijeb.v63i01.7040.